A simple bioreactor-based method to generate kidney organoids from pluripotent stem cells A Przepiorski, V Sander, T Tran, JA Hollywood, B Sorrenson, JH Shih, ... Stem Cell Reports 11 (2), 470-484, 2018 | 224 | 2018 |
Correction of the ΔF508 mutation in the cystic fibrosis transmembrane conductance regulator gene by zinc-finger nuclease homology-directed repair CM Lee, R Flynn, JA Hollywood, MF Scallan, PT Harrison BioResearch open access 1 (3), 99-108, 2012 | 140 | 2012 |
Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA DJ Sanz, JA Hollywood, MF Scallan, PT Harrison PloS one 12 (9), e0184009, 2017 | 102 | 2017 |
Use of human induced pluripotent stem cells and kidney organoids to develop a cysteamine/mTOR inhibition combination therapy for cystinosis JA Hollywood, A Przepiorski, RF D’Souza, S Sreebhavan, EJ Wolvetang, ... Journal of the american society of nephrology 31 (5), 962-982, 2020 | 66 | 2020 |
Analysis of gene repair tracts from Cas9/gRNA double-stranded breaks in the human CFTR gene JA Hollywood, CM Lee, MF Scallan, PT Harrison Scientific Reports 6 (1), 32230, 2016 | 37 | 2016 |
Impact of gene editing on the study of cystic fibrosis PT Harrison, DJ Sanz, JA Hollywood Human genetics 135, 983-992, 2016 | 19 | 2016 |
Validating TDP1 as an inhibition target for the development of chemosensitizers for camptothecin-based chemotherapy drugs E Leung, J Patel, JA Hollywood, A Zafar, P Tomek, D Barker, LI Pilkington, ... Oncology and Therapy 9 (2), 541-556, 2021 | 16 | 2021 |
Derivation of induced pluripotent stem cell lines from New Zealand donors JK Oh, A Przepiorski, HH Chang, RC Dodd, V Sander, B Sorrenson, ... Journal of the Royal Society of New Zealand 52 (1), 54-67, 2022 | 10 | 2022 |
In vitro and in vivo models to study nephropathic cystinosis PY Cheung, PT Harrison, AJ Davidson, JA Hollywood Cells 11 (1), 6, 2021 | 9 | 2021 |
Cystinosin-deficient rats recapitulate the phenotype of nephropathic cystinosis JA Hollywood, PK Kallingappa, PY Cheung, RM Martis, S Sreebhavan, ... American Journal of Physiology-Renal Physiology, 2022 | 8 | 2022 |
Auxiliary tools in tuberculosis. The hemolysis in pleural fluids underestimate the values of adenosine deaminase activity determined by the method of Giusti C Coitinho, C Rivas Revista Argentina de Microbiología 40 (2), 101-105, 2008 | 2 | 2008 |
Use of human iPSCs and kidney organoids to develop a cysteamine/mTOR inhibition combination therapy to treat cystinosis JA Hollywood, A Przepiorski, PT Harrison, EJ Wolvetang, AJ Davidson, ... bioRxiv, 595264, 2019 | 1 | 2019 |
# 512 Two are better than one: a new combination treatment for cystinosis PY Cheung, CH Wu, A Davidson, J Hollywood Nephrology Dialysis Transplantation 39 (Supplement_1), gfae069-0010-512, 2024 | | 2024 |
In Vitro and In Vivo Models to Study Nephropathic Cystinosis. Cells 2022, 11, 6 PY Cheung, PT Harrison, AJ Davidson, JA Hollywood Cellular and Molecular Mechanisms of Nephropathic Cystinosis, 69, 2021 | | 2021 |
Gene Editing of Stem Cells to Model and Treat Disease JA Hollywood, DJ Sanz, AJ Davidson, PT Harrison Current Stem Cell Reports 4, 253-263, 2018 | | 2018 |
Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA J Hollywood Public Library of Science (PLoS), 2017 | | 2017 |
Cas9 and Cpf1 gene editing of rare Cystic Fibrosis-causing mutations K Cavusoglu-Doran, P Harrison, MF Scallan, K Mention, JA Hollywood, ... HUMAN GENE THERAPY 28 (8), A7-A7, 2017 | | 2017 |
Correction of Multiple Cystic Fibrosis-Causing Variants by CFTR Superexon Homology-Independent Targeted Integration D Sanz, K Mention, K Cavusoglu, J Hollywood, M Scallan, P Harrison MOLECULAR THERAPY 25 (5), 300-300, 2017 | | 2017 |
Using induced pluripotent stem cells and kidney organoids to model cystinosis J Hollywood | | 2017 |
CRISPR/CAS9 BASED GENE EDITING OF CFTR DEEP INTRONIC MUTATIONS DJ Sanz, JA Hollywood, P Harrison PEDIATRIC PULMONOLOGY 51, 265-266, 2016 | | 2016 |